| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 134452-04-3 | PD 132002 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 2 | 185039-91-2 | PD166326 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 3 | 179598-53-9 | PD159790 |
≥98% | | 询价 |
| 4 | 162412-70-6 | PD-156707 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 5 | 181941-32-2 | PD-149164 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 6 | 154130-99-1 | PD-144418 |
≥98% | | 询价 |
| 7 | 140677-01-6 | PD-140548 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 8 | 134557-41-8 | PD-135666 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 9 | 179343-17-0 | PD089828 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 10 | 216163-53-0 | PD 174265 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 11 | 204066-82-0 | PD 168368 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 12 | 168570-35-2 | PD 161182 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 13 | 149092-00-2 | PD 160336 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 14 | 159614-69-4 | PD 154740 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 15 | 143037-36-9 | PD 142893 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 16 | 149027-97-4 | PD 140376 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 17 | 147208-55-7 | PD 140248 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 18 | 107334-06-5 | PD 138312 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 19 | 142642-31-7 | PD 138142 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 20 | 150351-31-8 | PD 135390 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 21 | 130325-35-8 | PD 135158 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 22 | | IPTBC |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 23 | 150351-30-7 | PD 134922 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 24 | 89592-45-0 | ZK93426 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 25 | 83910-44-5 | ZK93423 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 26 | 444088-20-4 | PD-217014 HCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 27 | 212631-61-3 | PD-198306 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 28 | 212631-67-9 | PD184161 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 29 | | Gypenoside L |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 30 | 190383-31-4 | PD168,077 |
≥98% | | 询价 |
| 31 | 475-20-7 | Longifolene |
≥98% | | 询价 |
| 32 | 76822-34-9 | Anisodine Hydrobromide |
≥98% | | 询价 |
| 33 | 31232-26-5 | Danitracen |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 34 | 120166-69-0 | R 59949 |
≥98% | | 询价 |
| 35 | 117-37-3 | Anisindione |
≥98% | | 询价 |
| 36 | 66635-85-6 | Anirolac |
≥98% | | 询价 |
| 37 | 72432-10-1 | Aniracetam |
≥98% | | 询价 |
| 38 | 83200-10-6 | Anipamil |
≥98% | | 询价 |
| 39 | 92-85-3 | Thianthrene |
≥98% | | 询价 |
| 40 | 64249-01-0 | Anilofos |
≥98% | | 询价 |
| 41 | 1404-48-4 | Relomycin |
≥98% | | 询价 |
| 42 | 20283-69-6 | Niddamycin |
≥98% | | 询价 |
| 43 | 101865-16-1 | Aniline,p-(5-phenylpentyloxy)-,methanesulfonate |
≥98% | | 询价 |
| 44 | 128007-31-8 | Arvanil |
≥98% | | 询价 |
| 45 | 39905-47-0 | Aniline,p-(decyloxy)- |
≥98% | | 询价 |
| 46 | 102559-27-3 | Aniline,p-(5-(p-phenoxyphenoxy)pentyloxy)- |
≥98% | | 询价 |
| 47 | 1609534-88-4 | ASM-024 |
≥98% | | 询价 |
| 48 | 110443-23-7 | Aniline,p-(5-(p-methoxyphenoxy)pentyloxy)- |
≥98% | | 询价 |
| 49 | 110684-98-5 | Aniline,4,4'-(nonamethylenedioxy)di-,dihydrochloride |
≥98% | | 询价 |
| 50 | 102321-36-8 | Aniline,p-(5-(p-ethoxyphenoxy)pentyloxy)- |
≥98% | | 询价 |
| 51 | 57181-86-9 | Aniline,p-(3-phenylpropoxy)- |
≥98% | | 询价 |
| 52 | 102759-19-3 | Aniline,N-methyl-p-(8-phenoxyoctyloxy)- |
≥98% | | 询价 |
| 53 | 25890-96-4 | Aniline,m-(2-(2-(diethylamino)ethoxy)ethyl)- |
≥98% | | 询价 |
| 54 | 102319-76-6 | Aniline,4,4'-(trimethylenedioxy)bis(N,N-dimethyl- |
≥98% | | 询价 |
| 55 | 41806-51-3 | W10294A |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 56 | 6790-09-6 | PEG13 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 57 | 6809-70-7 | PEG12 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 58 | 62573-11-9 | PEG10-Tos |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 59 | 70458-92-3 | Pefloxacin(Pefloxacinium) |
≥98% | | 询价 |
| 60 | 19504-77-9 | Pecilocin |
≥98% | 50mg, 100mg, 250mg | 询价 |
m.cnreagent.com